Research programme: trimerised human growth hormone - Borean Pharma
Alternative Names: Trimeric somatropin analogues - Borean PharmaLatest Information Update: 09 Aug 2007
At a glance
- Originator Borean Pharma
- Class
- Mechanism of Action Somatotropin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Growth disorders
Most Recent Events
- 09 Aug 2007 Discontinued - Preclinical for Growth disorders in Denmark (unspecified route)
- 27 Feb 2004 Preclinical trials in Growth disorders in Denmark (unspecified route)